Bridgefront Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Bridgefront Capital's JNJ Position: Q1 2026 in Review
Bridgefront Capital sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 3,561 shares — an estimated $737K sold.
Bridgefront Capital first reported a position in JNJ in Q1 2021 and held it in 11 quarters. The position peaked at $1.36M in Q1 2023. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Bridgefront Capital reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
- Bridgefront Capital sold 3,561 Johnson & Johnson shares in Q1 2026, an estimated $737K.
- Bridgefront Capital first reported a position in Johnson & Johnson in Q1 2021 and held it in 11 quarters.
- Bridgefront Capital's Johnson & Johnson position peaked at $1.36M in Q1 2023.
- 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.